期刊文献+

Cervical cancer prevention in China: where are we now, and what's next? 被引量:1

下载PDF
导出
摘要 Cervical cancer(CC) epidemiology CC, the fourth most frequently diagnosed malignancy in women worldwide, is a major global health challenge, particularly in low-resource regions. Approximately 88.1% of the 604,000 CC new cases occurred in low-and middle-income countries in 2020, and more than 90% of the 342,000 CC deaths occurred in low-and middle-income countries in 2020~1.
出处 《Cancer Biology & Medicine》 SCIE CAS CSCD 2024年第3期213-217,共5页 癌症生物学与医学(英文版)
基金 supported by the Bill and Melinda Gates Foundation [Research on Expending Human Papillomavirus (HPV) Vaccination, Grant Number: INV – 006373 and Implementation Research around the Pilots of Cervical Cancer Elimination, Grant Number: INV-031449]。
  • 相关文献

参考文献7

二级参考文献31

共引文献530

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部